Low COAT Platelets Are Frequent in Patients with Bleeding Disorders of Unknown Cause (BDUC) and Can Be Enhanced By DDAVP
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Angenieux C, Couvidou A, Brouard N, Eckly A, Dupuis A, Mangin P Res Pract Thromb Haemost. 2023; 7(1):100006.
PMID: 36970736 PMC: 10031328. DOI: 10.1016/j.rpth.2022.100006.
Procoagulant platelets: novel players in thromboinflammation.
Denorme F, Campbell R Am J Physiol Cell Physiol. 2022; 323(4):C951-C958.
PMID: 35993516 PMC: 9484986. DOI: 10.1152/ajpcell.00252.2022.
References
1.
Aliotta A, Calderara D, Zermatten M, Marchetti M, Alberio L
. Thrombocytopathies: Not Just Aggregation Defects-The Clinical Relevance of Procoagulant Platelets. J Clin Med. 2021; 10(5).
PMC: 7956450.
DOI: 10.3390/jcm10050894.
View
2.
Kaufmann J, Vischer U
. Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP). J Thromb Haemost. 2003; 1(4):682-9.
DOI: 10.1046/j.1538-7836.2003.00190.x.
View
3.
Cattaneo M, Cerletti C, Harrison P, Hayward C, Kenny D, Nugent D
. Recommendations for the Standardization of Light Transmission Aggregometry: A Consensus of the Working Party from the Platelet Physiology Subcommittee of SSC/ISTH. J Thromb Haemost. 2013; .
DOI: 10.1111/jth.12231.
View
4.
Dawood B, Lowe G, Lordkipanidze M, Bem D, Daly M, Makris M
. Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel. Blood. 2012; 120(25):5041-9.
PMC: 3790949.
DOI: 10.1182/blood-2012-07-444281.
View
5.
Colucci G, Stutz M, Rochat S, Conte T, Pavicic M, Reusser M
. The effect of desmopressin on platelet function: a selective enhancement of procoagulant COAT platelets in patients with primary platelet function defects. Blood. 2014; 123(12):1905-16.
DOI: 10.1182/blood-2013-04-497123.
View